PROQR THERAPEUTICS (Germany) Analysis

PROQR Stock Analysis Notes

About 21.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.92. PROQR THERAPEUTICS had not issued any dividends in recent years. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands. PROQR THERAPEUTICS is traded on Frankfurt Stock Exchange in Germany. For more info on PROQR THERAPEUTICS EO 04 please contact Daniel Boer at 31 88 166 7000 or go to http://www.proqr.com.

PROQR THERAPEUTICS Investment Alerts

PROQR Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 207.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PROQR THERAPEUTICS's market, we take the total number of its shares issued and multiply it by PROQR THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 29th of November, PROQR THERAPEUTICS holds the semi deviation of 3.01, and Risk Adjusted Performance of 0.0944. PROQR THERAPEUTICS technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check PROQR THERAPEUTICS downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if PROQR THERAPEUTICS is priced favorably, providing market reflects its current price of 3.41 per share.

PROQR THERAPEUTICS Price Movement Analysis

PROQR THERAPEUTICS Outstanding Bonds

PROQR THERAPEUTICS Predictive Daily Indicators

PROQR THERAPEUTICS Forecast Models

PROQR THERAPEUTICS's time-series forecasting models are one of many PROQR THERAPEUTICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PROQR THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how PROQR THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PROQR shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PROQR THERAPEUTICS. By using and applying PROQR Stock analysis, traders can create a robust methodology for identifying PROQR entry and exit points for their positions.

When running PROQR THERAPEUTICS's price analysis, check to measure PROQR THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PROQR THERAPEUTICS is operating at the current time. Most of PROQR THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of PROQR THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PROQR THERAPEUTICS's price. Additionally, you may evaluate how the addition of PROQR THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.